Pharmaceutical compositions comprising valsartan and NEP inhibitors

Details for Australian Patent Application No. 2006202999 (hide)

Owner Novartis AG

Inventors Webb, Randy Lee; Ksander, Gary Michael

Agent Davies Collison Cave

Pub. Number AU-A-2006202999

Parent 2003206738

Filing date 13 July 2006

Wipo publication date 3 August 2006

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/192 (2006.01)

A61K 31/216 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07C 215/10 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 233/47 (2006.01) Carboxylic acid amides

Event Publications

3 August 2006 Application Open to Public Inspection

  Published as AU-A-2006202999

3 August 2006 Complete Application Filed

28 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203000-Sensor assembly for automatic dryer

2006202998-Standardization of catheter-based treatment for atrial fibrillation